Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

A Bullish Sign Appears On Grifols's Chart

If history is any guide, there may be good fortune ahead for shares of Grifols (NASDAQ:GRFS). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Ingles Markets: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Ingles Markets (NASDAQ:IMKTA).

Benzinga

5 Value Stocks To Watch In The Consumer Defensive Sector

Understanding Value Stocks

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

BofA Says Canopy Stock Is 'A Show Me Story,' Lowers Price Target

Canopy Growth Corporation (NASDAQ: CGC)

Benzinga

Labor Market Is Tight Yet Layoffs Surge As Tesla, Coinbase, Netflix And Others Cut Staff

The recent unemployment claims numbers confirm the Federal Reserve's assertion that the labor market is tight. However, layoffs are intensifying, particularly in the tech and cryptocurrency sectors.

Benzinga

$1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth This Much Today

Palo Alto Networks (NASDAQ:PANW) has outperformed the market over the past 10 years by 14.52% on an annualized basis producing an average annual return of 25.16%. Currently, Palo Alto Networks has a market capitalization of $49.95 billion.

Benzinga

Expert Ratings for Huntington Bancshares

Within the last quarter, Huntington Bancshares (NASDAQ:HBAN) has observed the following analyst ratings:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Netflix Crashes As 'Stranger Things 4' Volume 2 Goes Live: Was Vecna To Blame?

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

Benzinga

What 6 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical

Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter:

Benzinga

Here's How Much $100 Invested In O'Reilly Automotive 15 Years Ago Would Be Worth Today

O'Reilly Automotive (NASDAQ:ORLY) has outperformed the market over the past 15 years by 14.76% on an annualized basis producing an average annual return of 20.97%. Currently, O'Reilly Automotive has a market capitalization of $41.50 billion.

Benzinga

Where Pinnacle Finl Partners Stands With Analysts

Analysts have provided the following ratings for Pinnacle Finl Partners (NASDAQ:PNFP) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022

Upgrades

Benzinga

Nemaura Medical's Return On Capital Employed Insights

Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.41%, resulting in a loss of $3.62 million.

Benzinga

Simply Good Foods's Return On Capital Employed Overview

According to Benzinga Pro, during Q3, Simply Good Foods (NASDAQ:SMPL) earned $38.83 million, a 110.36% increase from the preceding quarter. Simply Good Foods also posted a total of $316.53 million in sales, a 6.68% increase since Q2.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Celldex's Barzolvolimab Shows Rapid, Durable Responses In Early Urticaria Study

Celldex Therapeutics Inc (NASDAQ:CLDX) announced interim data from Phase 1b trial of barzolvolimab in chronic spontaneous urticaria (CSU) refractory to antihistamines. CSU is characterized by the occurrence of hives or weals for six weeks or longer without identifiable specific triggers or causes. Data show that multiple doses of barzolvolimab resulted in dose-dependent decreases…

Benzinga

Why U.S. Stocks Are Trading Higher, Manufacturing Report And More

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Benzinga

Here's Why VerifyMe Shares Are Trading Higher Today

VerifyMe, Inc (NASDAQ:VRME) elected not to extend the period for a special purpose acquisition company (SPAC) merger with G3 VRM Acquisition Corp (NASDAQ:GGGVU). VerifyMe's board determined that it was not in its best interests to allocate additional financial capital at this time for the SPAC to consummate a business combination. Instead, it will focus on…

Benzinga

What 8 Analyst Ratings Have To Say About Paramount Global

Analysts have provided the following ratings for Paramount Global (NASDAQ:PARA) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying

U.S. stocks opened slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga

Analyst Ratings for Wingstop

Analysts have provided the following ratings for Wingstop (NASDAQ:WING) within the last quarter:

Benzinga

Expert Ratings for Live Oak Bancshares

Analysts have provided the following ratings for Live Oak Bancshares (NASDAQ:LOB) within the last quarter:

Benzinga

7 Analysts Have This to Say About Iovance Biotherapeutics

Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter:

Benzinga

China Cracks Down On Counterfeit Investment Platforms

China's cyberspace regulator has cracked down on counterfeit investment platforms, Reuters reports.

Benzinga

Here's Why Micron, TSMC, AMD, Nvidia, Qualcomm And Other Chipmakers Are Trading Lower Premarket

Chipmaking stocks are bleeding post Micron Technology, Inc's (NASDAQ: MU)

Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 333 334 335 336

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.